Christian Hermansen, MD, Associate Director/ Regional Medical Director. Dr. "Herm" graduated from Jefferson Medical College and was introduced to Lancaster shortly thereafter. He graduated from the Lancaster General Health Family Medicine Residency Program and was honored with the Society for Teachers in Family Medicine Resident of the Year award. After two wonderful years in Christian-based private practice in New Jersey, he was called to Lancaster to combine private and academic family medicine. He also serves as Managing Physician of Downtown Family Medicine and oversees the LGHP Academic Practices as Regional Medical Director. He is a past recipient of the Faculty Teacher of the Year and serves as deacon of his church. Feel free to discuss financial peace, sports (Go Phillies, Sixers and Eagles! #TrusttheProcess #PhillyPhilly), or the book you're currently reading when you see him. After work, however, Dr. Hermansen can't wait to enjoy family life with his wife, Heather, and his three boys, Timothy, Benjamin and Nathaniel and coach baseball in the community. Follow more of the activities of the Residency Program on twitter: https://twitter.com/#!/LGFamMedRes
Michael R. Pavlica, MD
Michael R. Pavlica, MD
Specialist, Diseases and Surgery of the Retina and Vitreous
Director, Diabetic Eye Care and Macular Degeneration Center, Family Eye Group
Dr. Pavlica specializes in diseases and surgery of the retina and vitreous. He received his MD from New York University School of Medicine in 1990, and then completed an internal medicine internship in Boston at Beth Israel Hospital, Harvard Medical School. Dr. Pavlica completed his ophthalmology residency at Boston Medical Center, followed by two-years of fellowship training at Baylor College of Medicine in Houston, Texas.
Dr. Pavlica has extensive training in the medical and surgical management of diabetic retinopathy, macular degeneration, retinal detachments, macular holes, macular pucker, and retinal vein occlusions, among others. He is the author of the chapter Subretinal Neovascularization in the newest edition of Master Techniques in Ophthalmic Surgery. He has participated in numerous studies and published articles as an investigator with the Diabetic Retinopathy Clinical Research Network. Dr. Pavlica recently co-authored an article with the network in Ophthalmology, the journal of the American Association of Ophthalmology reporting on factors associated with vision and edema outcomes when treating proliferative diabetic retinopathy with panretinal photocoagulation versus intravitreal injections. He has authored articles in the Archives of Ophthalmology and Investigative Ophthalmology and Visual Science as well. A study involving various types of treatment for diabetic retinopathy in which he was an investigator has been published in the New England Journal of Medicine. He has served as a reviewer for the journal Ophthalmology and BMC Ophthalmology.
He is a member of the American Academy of Ophthalmology, the American Society of Retinal Specialists, and the American Society of Cataract and Refractive Surgeons. Dr. Pavlica is a past president of the Lancaster County Medical Society.
Accreditation Statement In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and DKBmed, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points [and patient safety MOC credit] in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
This Enduring Material activity, Optimizing Disease Management: A Vision for Diabetic Eye Screening, has been reviewed and is acceptable for credit by the American Academy of Family Physicians. Term of approval begins 08/23/2018. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Approved for 1.0 AAFP Prescribed credits.
Target Audience This activity is intended for primary care clinicians and allied health providers who manage patients with type 2 diabetes.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest. The faculty reported no financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity.
Planners and Managers
The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose.
The following DKB planners and managers Stan Pogroszewski, and Rachel Deerr hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Disclosure of Unlabeled Use This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Jointly provided by Postgraduate Institute for Medicine and DKBmed, LLC.
Estimated time to complete activity: 1.0 hours
Method of Participating and Request for Credit There are no fees for participation in this CME activity. To receive credit, participants must 1) read the learning objectives and disclosure statements, 2) complete the educational activity and 3) complete the post-test and activity evaluation.
Supported Browsers: Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above.